UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000003190
Receipt No. R000003651
Scientific Title Cancer Vaccine Therapy using Epitope Peptide Restricted to HLA-A*02 (URLC10) in Patients with Non-small Cell Lung Cancer Refractory to Standard Therapy (Phase I study)
Date of disclosure of the study information 2010/02/16
Last modified on 2019/03/31 22:37:37

No. Disposal Last modified on Item of update
1 Insert 2010/02/16 10:43:05
2 Update 2010/02/16 16:26:44 Anticipated trial start date
3 Update 2010/02/20 19:05:21 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
4 Update 2012/05/04 11:42:22 Last name of lead principal investigator
Name of person sending information
Post marketing survey by drug manufacture etc., specified by Japanese law.
5 Update 2012/05/04 11:42:46 Type of intervention
6 Update 2012/12/06 14:57:42 Last follow-up date
7 Update 2019/03/31 22:37:37 Recruitment status
Date of IRB
Last follow-up date

Contact us.